U.S. Navy
About U.S. Navy
22 articles about U.S. Navy
-
Biomimicry, looking at how things are done in nature and applying that to solve problems, is utilized by many researchers. BioSpace looks at some examples of how scientists are performing cutting-edge research using biomimicry.
-
US Navy Veterans Mesothelioma Advocate Now Urge Navy Veterans with Mesothelioma to Call for Instant Access to The Nation's Top Lawyers for a Compensation Settlement and Disability Payments
5/1/2018
The US Navy Veterans Mesothelioma Advocate says, "We are urging Navy Veterans who have recently been diagnosed with mesothelioma to not get stuck at the back of the financial compensation line because they hired unqualified or inexperienced lawyer(s) to assist with their bulk payment compensation claim or their VA disability payment.
-
Evolva A/S To Co-Develop Next-Generation Materials With U.S. Navy
4/11/2016
-
Brainsway Partners With U.S. Navy To Provide Innovative Deep Transcranial Magnetic Stimulation (Deep TMS) For Depression Treatment
10/6/2015
-
U.S. Navy Selects Carestream Health, Inc.’s Medical Image Management System For Its USNS Mercy Hospital Ship
3/10/2015
-
Carestream Health, Inc. Is First Company To Receive U.S. Navy Certification To Implement Medical Image Management Systems
12/22/2014
-
CEL-SCI & U.S. Navy Administer Multikine To First Volunteer Patient In Phase I Clinical Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients
9/29/2014
-
U.S. Navy Approves Start Of CEL-SCI’s Phase I Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients
2/3/2014
-
CEL-SCI Announces Cooperative Research and Development Agreement (CRADA) for Multikine With U.S. Navy
10/7/2013
-
Sparton Corporation Venture Awarded $17.9 Million U.S. Navy Contract
2/8/2013
-
Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With U.S. Navy to Investigate the Use of Oxycyte PFC Emulsion as an Adjunctive Treatment of Complex Infected Wounds and Related Injuries
10/3/2012
-
Dental Equipment-Maker A-dec Lands $39.5 Million U.S. Navy Contract
8/17/2012
-
Oxygen Biotherapeutics, Inc. and U.S. Navy Expand Collaboration With a Cooperative Research & Development Agreement to Study Oxycyte® for Treatment of Hemorrhagic Shock
8/2/2012
-
U.S. Navy Advances Dengue DNA Vaccine Using Vical Incorporated's Vaxfectin(R) Adjuvant
3/5/2012
-
U.S. Navy Doctor's Drug Study Under Scrutiny
5/20/2011
-
Sangart, Inc. Announces Cooperative Research and Development Agreement With the U.S. Navy to Evaluate MP4 Molecule in Traumatic Brain Injury
12/6/2010
-
ADA Technologies Awarded $80K Contract from U.S. Navy
9/29/2010
-
Oxygen Biotherapeutics, Inc. Signs CRADA With U.S. Navy to Study Treatment of Decompression Sickness Using Oxycyte(R) Emulsion
8/2/2010
-
FDA Advisory Committee To Consider U.S. Navy's Proposed 'RESUS' Trauma Trial At July 2006 Meeting
5/26/2006
-
CEL-SCI Extends Agreement With U.S. Navy For CEL-1000 Drug
4/20/2006